One way this could occur is MBD2 binding to hypermethylated promoters of tumor suppressor genes and contributing to their transcriptional silencing, which has been shown to occur in multiple human cancer cell lines (Lopez-Serra et al., 2008). The gene discussed is MBD2; the disease is cancer.